• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    The Overdose Response Program

    Naloxone Saves Lives

    ​​Starting June 1, 2017, anyone can get naloxone at a Maryland pharmacy without a prescription. To learn more click here​​
     ​

    Naloxone (NARCAN®, EVZIO®) is a prescription medication that safely and effectively reverses an opioid overdose.

    Opioid is a class of drugs that includes heroin and prescription pain relievers like oxycodone (OxyContin®, Percocet®), hydrocodone (Vicodin®, Lortab®), oxymorphone (Opana®), hydromorphone (Dilaudid®), morphine (MS Contin®), fentanyl (Duragesic®) and methadone.

    ​Naloxone does NOT:                                                         

    • ​Cause Addictions 
    • 'Enable' someone's drug use or addiction 
    • Give the user a 'high' 
    • Have much potential to cause harm when administered appropriately, even if the person is not actually experiencing an opioid overdose. 

    Doctors, paramedics, and other healthcare providers have used it for decades.

    Now many more people in Maryland can get access to naloxone to save a life.


    How to Get Naloxone


    1.  Ask your doctor – Maryland law allows any healthcare provider who can prescribe drugs in Maryland (including physicians, physician assistants,advance practice nurses, dentists and others) to prescribe naloxone. Your provider can prescribe ​you naloxone if you are personally at risk for opioid overdose OR if you are likely to witness an overdose and be in a position to respond. State law includes legal protections for you and your provider (see below).


    2.  Maryland Overdose Response Program –The Maryland Overdose Response Program (ORP)​​ offers in-person, hands-on training and certification in recognizing and responding to opioid overdose with naloxone. Most OR​P trainings​​ are free to attend and also provide naloxone to trainees at no charge. Visit the ORP website or cont​act the ORP​ for more information.


    UPDATE: A statewide standing order​ is now in effect allowing pharmacists to dispense naloxone to ORP certificate holders without a prescription.

    Pharmacies S​tocking Naloxone​​​ ​​​​(updated 12/19/2016) PDF Version​– The pharmacies on this list have been identified as currently stocking naloxone by the pharmacies’ corporate offices. Any individual may visit a participating pharmacy to get naloxone without a prescription under the statewide standing order. Individuals should ask to speak to a pharmacist about naloxone. 

    Naloxone Products

    Naloxone can be injected into a muscle (intramuscular) or vein (intravenous) or sprayed into the nose (intranasal). Naloxone is often provided as part of a “rescue kit” that also includes:​

    • ​paraphernalia for administration (nasal atomizer, syringe, needle) 
    • alcohol swabs 
    • non-latex gloves 
    • plastic face shield for rescue breathing 
    • printed materials with information on opioid overdose response and naloxone administration, overdose prevention tips and accessing addiction treatment and recovery services


    There are 4 types of naloxone products available:


         ​ 1. For intranasal administration: 2mg/2mL single-dose Luer-Jet prefilled syringe. Include one             luer-lock mucosal atomization device (MAD 300) per dose dispensed.

           Directions for use: Spray 1 mL in each nostril. Repeat after 3 minutes if no or minimal response.​​​

    naloxone administering naloxonenaloxone  
    ​

    2. For intranasal administration: 4 mg dose

    Directions for use: Place the tip of the nozzle in either nostril until your fingers touch the bottom of the patient’s nose.  Press the plunger firmly to release the dose into the patient’s nose. Remove the device from the nostril and discard.  Using a new device, repeat after 3 minutes if no or minimal response​


      
    3. For intramuscular injection:​ 0.4/mL in 1mL single dose vials. Include one 3cc, 23g, 1'syringe per dose dispensed. Include face shield for rescue breathing and alcohol swabs if available. 
    Directions for use: Inject 1mL in shoulder or thigh. Repeat after 3 minutes if no or minimal response. 
     
     3-1.png3-2.png
     
            4. For intramuscular or subcutaneous injection: EVZIO® 2mg/0.4mL auto-injector, 
             #1 Two-Pack.
             Directions for use: Follow audio instructions from device. Place on thigh and inject 0.4 mL.                  Repeat after 3 minutes if no or minimal response.  
     4-1.png4-2.png4-3.png
     
     


    ​​​​​​
    ​​​